These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9871435)

  • 1. The role of striatal glutamate receptors in models of Parkinson's disease.
    Ossowska K; Lorenc-Koci E; Konieczny J; Wolfarth S
    Amino Acids; 1998; 14(1-3):11-5. PubMed ID: 9871435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-701,324, a selective antagonist at the glycine site of the NMDA receptor, counteracts haloperidol-induced muscle rigidity in rats.
    Konieczny J; Ossowska K; Schulze G; Coper H; Wolfarth S
    Psychopharmacology (Berl); 1999 Apr; 143(3):235-43. PubMed ID: 10353425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the glycine site of NMDA receptors in rostral and intermediate-caudal parts of the striatum to the regulation of muscle tone in rats.
    Lorenc-Koci E; Konieczny J; Wolfarth S
    Brain Res; 1998 May; 793(1-2):315-20. PubMed ID: 9630698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of dizocilpine (MK-801) on the reserpine-enhanced electromyographic stretch reflex in rats.
    Ossowska K; Lorenc-Koci E; Schulze G; Wolfarth S
    Neurosci Lett; 1996 Jan; 203(2):73-6. PubMed ID: 8834096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMDA receptors in the rostral and intermediate-caudal striatum play an opposite role in regulation of the muscle tone in rats.
    Ossowska K; Konieczny J
    Pol J Pharmacol; 1996; 48(3):261-7. PubMed ID: 9112661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of metabotropic glutamate receptor (mGluR) ligands in parkinsonian muscle rigidity.
    Wolfarth S; Konieczny J; Lorenc-Koci E; Ossowska K; Pilc A
    Amino Acids; 2000; 19(1):95-101. PubMed ID: 11026478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat.
    Nash JE; Brotchie JM
    Mov Disord; 2002 May; 17(3):455-66. PubMed ID: 12112191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiparkinsonian action of MK-801 on the reserpine-induced rigidity: a mechanomyographic analysis.
    Ossowska K; Lorenc-Koci E; Wolfarth S
    J Neural Transm Park Dis Dement Sect; 1994; 7(2):143-52. PubMed ID: 7710666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (S)-4C3HPG, a mixed group I mGlu receptor antagonist and a group II agonist, administered intrastriatally, counteracts parkinsonian-like muscle rigidity in rats.
    Lorenc-Koci E; Wardas J; Wolfarth S; Pilc A
    Brain Res; 2001 Jun; 903(1-2):177-84. PubMed ID: 11382401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of NR2B-containing N-methyl-D-aspartate receptors in haloperidol-induced c-Fos expression in the striatum and nucleus accumbens.
    Lee J; Rajakumar N
    Neuroscience; 2003; 122(3):739-45. PubMed ID: 14622917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of excitatory amino acid release by N-methyl-D-aspartate receptors in rat striatum: in vivo microdialysis studies.
    Bustos G; Abarca J; Forray MI; Gysling K; Bradberry CW; Roth RH
    Brain Res; 1992 Jul; 585(1-2):105-15. PubMed ID: 1355000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GlycineB antagonists and partial agonists in rodent models of Parkinson's disease--comparison with uncompetitive N-methyl-D-aspartate receptor antagonist.
    Karcz-Kubicha M; Lorenz B; Danysz W
    Neuropharmacology; 1999 Jan; 38(1):109-19. PubMed ID: 10193902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MK 801 reverses haloperidol-induced catalepsy from both striatal and extrastriatal sites in the rat brain.
    Kaur S; Ozer H; Starr M
    Eur J Pharmacol; 1997 Aug; 332(2):153-60. PubMed ID: 9286616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats.
    Wardas J; Konieczny J; Lorenc-Koci E
    Synapse; 2001 Aug; 41(2):160-71. PubMed ID: 11400182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens.
    Hussain N; Flumerfelt BA; Rajakumar N
    Neuroscience; 2001; 102(2):391-9. PubMed ID: 11166125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glutamate and MK-801 on the metabolism of dopamine in the striatum of normal and parkinsonian rats.
    Duan CL; Sun XH; Ji M; Yang H
    Sheng Li Xue Bao; 2005 Feb; 57(1):71-6. PubMed ID: 15719139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
    Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
    Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of NMDA receptors by MK-801 reverses the changes in striatal glutamate immunolabeling in 6-OHDA-lesioned rats.
    Robinson S; Krentz L; Moore C; Meshul CK
    Synapse; 2001 Oct; 42(1):54-61. PubMed ID: 11668591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of glutamate, aspartate and gamma-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway.
    Abarca J; Bustos G
    Neurochem Int; 1999 Jul; 35(1):19-33. PubMed ID: 10403427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.